Article
Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Nov 2005
Thomas Roman K, Sos Martin L, Zander Thomas, Mani Ozlem, Popov Alexey, Berenbrinker Daniel, Smola-Hess Sigrun, Schultze Joachim L, Wolf Jürgen
Abstract excerpt
PURPOSE: Defective apoptosis signaling is a typical feature of classic Hodgkin's lymphoma, multiple myeloma, and activated B-cell-like diffuse large B-cell lymphoma. In these malignancies, the transcription factor nuclear factor-kappaB (NF-kappaB) is a critical mediator of apoptosis resistance and oncogenic growth, making it an attractive therapeutic target. Here, we sought to determine how to overcome apoptosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
